JP2021536466A5 - - Google Patents
Info
- Publication number
- JP2021536466A5 JP2021536466A5 JP2021512652A JP2021512652A JP2021536466A5 JP 2021536466 A5 JP2021536466 A5 JP 2021536466A5 JP 2021512652 A JP2021512652 A JP 2021512652A JP 2021512652 A JP2021512652 A JP 2021512652A JP 2021536466 A5 JP2021536466 A5 JP 2021536466A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- film according
- activator
- film
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025023573A JP2025093925A (ja) | 2018-09-07 | 2025-02-17 | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862728187P | 2018-09-07 | 2018-09-07 | |
| US62/728,187 | 2018-09-07 | ||
| US201862732720P | 2018-09-18 | 2018-09-18 | |
| US62/732,720 | 2018-09-18 | ||
| PCT/US2019/049725 WO2020051317A1 (en) | 2018-09-07 | 2019-09-05 | Oral film compositions and dosage forms having precise active dissolution profiles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025023573A Division JP2025093925A (ja) | 2018-09-07 | 2025-02-17 | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021536466A JP2021536466A (ja) | 2021-12-27 |
| JP2021536466A5 true JP2021536466A5 (cg-RX-API-DMAC10.html) | 2022-09-13 |
| JP7637616B2 JP7637616B2 (ja) | 2025-02-28 |
Family
ID=68425244
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512652A Active JP7637616B2 (ja) | 2018-09-07 | 2019-09-05 | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
| JP2025023573A Pending JP2025093925A (ja) | 2018-09-07 | 2025-02-17 | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025023573A Pending JP2025093925A (ja) | 2018-09-07 | 2025-02-17 | 厳密な活性剤溶解プロファイルを有する口腔用フィルム組成物及び剤形 |
Country Status (7)
| Country | Link |
|---|---|
| US (5) | US11541002B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3846778A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP7637616B2 (cg-RX-API-DMAC10.html) |
| CN (2) | CN112955124A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112021004053A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3110997A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020051317A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210346385A1 (en) * | 2018-09-21 | 2021-11-11 | MSB Holdings, Inc | Taste-masked dosage forms |
| US11331309B2 (en) * | 2019-06-05 | 2022-05-17 | Cure Pharmaceutical Holding Corp. | Methods and compositions for improving sleep |
| EP3895692A1 (en) * | 2020-04-15 | 2021-10-20 | LTS Lohmann Therapie-Systeme AG | Oral thin film with smooth fused film |
| CN112697937A (zh) * | 2020-12-18 | 2021-04-23 | 卓和药业集团有限公司 | 泊沙康唑肠溶片溶出度的分析方法 |
| US20220347117A1 (en) * | 2021-03-09 | 2022-11-03 | Aquestive Therapeutics, Inc. | Dosage forms having equivalent biocomparable profiles |
| CN113311124B (zh) * | 2021-06-08 | 2023-11-14 | 湖南慧泽生物医药科技有限公司 | 模拟药剂在体释放及吸收过程的二室模型实验装置 |
| CN115671078A (zh) * | 2021-07-28 | 2023-02-03 | 上海博志研新药物技术有限公司 | 一种依匹斯汀口溶膜组合物、其制备方法及应用 |
| CN114010575B (zh) * | 2021-10-22 | 2024-06-28 | 江苏谛奇医药科技有限公司 | 新斯的明及其衍生物的新制剂 |
| KR20240093850A (ko) * | 2021-10-22 | 2024-06-24 | 어퀘스티브 테라퓨틱스, 아이엔씨. | 개선된 안정성 프로파일을 갖는 약제학적 조성물 |
| WO2023078366A1 (zh) * | 2021-11-04 | 2023-05-11 | 上海博志研新药物技术有限公司 | 一种盐酸鲁拉西酮口溶膜组合物、其制备方法及应用 |
| CN116211833A (zh) * | 2021-11-30 | 2023-06-06 | 南京海辰药业股份有限公司 | 一种咪唑立宾口腔速溶膜剂及其制备方法 |
| CN114983984B (zh) * | 2022-07-26 | 2023-09-01 | 山东达因海洋生物制药股份有限公司 | 一种用于哮喘治疗复方口溶膜剂及其制备方法 |
| CN119909044A (zh) * | 2023-10-31 | 2025-05-02 | 浙江紫藤药业科技有限公司 | 一种口腔膜剂及其制备方法 |
| JP7659339B1 (ja) | 2023-11-21 | 2025-04-09 | 東海カプセル株式会社 | ピモベンダンを含有する経口フィルム製剤 |
| CN117414352A (zh) * | 2023-11-22 | 2024-01-19 | 湖北广济医药科技有限公司 | 一种瑞美吉泮口溶膜剂及其制备方法 |
| CN117631135B (zh) * | 2024-01-25 | 2024-04-09 | 四川大学 | 一种双功能柔性水凝胶光纤及其制备方法和应用 |
| CN118576571B (zh) * | 2024-05-31 | 2025-02-14 | 浙江大学 | 一种药物释放曲线可定制的口服膜剂及其制备方法 |
| WO2025261492A1 (zh) * | 2024-06-20 | 2025-12-26 | 广州玻思韬控释药业有限公司 | 一种秋水仙碱膜剂 |
| TW202604479A (zh) * | 2024-06-26 | 2026-02-01 | 大陸商浙江同源康醫藥股份有限公司 | 依達拉奉口腔溶膜速釋製劑組合物及其製劑和用途 |
| US20260027045A1 (en) * | 2024-07-23 | 2026-01-29 | Aquestive Therapeutics, Inc. | Methods of administering enhanced delivery epinephrine and prodrug compositions |
| CN119139272A (zh) * | 2024-09-02 | 2024-12-17 | 华中药业股份有限公司 | 一种艾司唑仑口腔速溶膜剂及其制备方法 |
| CN118903065B (zh) * | 2024-10-12 | 2025-02-07 | 山东则正医药技术有限公司 | 一种卢美哌隆口溶膜掩味组合物、其制备方法及应用 |
| WO2026150511A1 (ja) * | 2025-01-08 | 2026-07-16 | 東海カプセル株式会社 | ピモベンダンを含有する経口フィルム製剤 |
| CN119970685B (zh) * | 2025-02-18 | 2025-10-14 | 杭州成邦医药科技有限公司 | 一种卢美哌隆或其盐的膜剂与其制备方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4631837A (en) | 1985-05-31 | 1986-12-30 | Magoon Richard E | Method and apparatus for drying fruit pulp and the like |
| US6713471B1 (en) | 1999-06-15 | 2004-03-30 | Bristol-Myers Squibb Pharma Company | Substituted heterocycle fused gamma-carbolines |
| US7071186B2 (en) | 1999-06-15 | 2006-07-04 | Bristol-Myers Squibb Pharma Co. | Substituted heterocycle fused gamma-carbolines |
| WO2000077001A1 (en) | 1999-06-15 | 2000-12-21 | Du Pont Pharmaceuticals Company | Substituted heterocycle fused gamma-carbolines |
| US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
| US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
| US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| US8012505B2 (en) * | 2003-02-28 | 2011-09-06 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| US7906140B2 (en) * | 2004-06-17 | 2011-03-15 | Virun, Inc. | Compositions for mucosal delivery of agents |
| MX394214B (es) | 2007-03-12 | 2025-03-24 | Intra Cellular Therapies Inc | Sintesis de gamma-carbolinas fusionadas con heterociclo substituido. |
| ES2530090T3 (es) | 2008-03-12 | 2015-02-26 | Intra-Cellular Therapies, Inc. | Sólido de gamma-carbolinas fusionadas con heterociclo sustituido |
| CA2725342C (en) | 2008-05-27 | 2024-02-20 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for sleep disorders and other disorders |
| EP2448554A4 (en) | 2009-06-29 | 2014-03-12 | Oreal | REFRESHING CREAM BASE IN YELLOW |
| WO2011053251A1 (en) | 2009-10-30 | 2011-05-05 | Ix Biopharma Pte Ltd | Fast dissolving solid dosage form |
| US8956685B2 (en) | 2010-02-24 | 2015-02-17 | Monosol Rx, Llc | Use of dams to improve yield in film processing |
| US8993572B2 (en) | 2010-04-22 | 2015-03-31 | Intra-Cellular Therapies, Inc. | Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives |
| CN108175762A (zh) | 2010-09-23 | 2018-06-19 | 莫诺索尔克斯有限公司 | 用于直接在包装表面上形成药用产品的方法和系统 |
| US11129799B2 (en) | 2011-04-12 | 2021-09-28 | Aquestive Therapeutics, Inc. | Dual lane coating |
| US20130156823A1 (en) * | 2011-12-20 | 2013-06-20 | MAP Pharmacauticals, Inc. | Excipient-free Aerosol Formulation |
| US9428506B2 (en) | 2012-04-14 | 2016-08-30 | Intra-Cellular Therapies, Inc. | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders |
| JP5952646B2 (ja) | 2012-06-07 | 2016-07-13 | 救急薬品工業株式会社 | 口腔内溶解型フィルム製剤 |
| WO2014145192A1 (en) | 2013-03-15 | 2014-09-18 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR102967223B1 (ko) | 2013-12-03 | 2026-05-19 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
| US9745300B2 (en) | 2014-04-04 | 2017-08-29 | Intra-Cellular Therapies, Inc. | Organic compounds |
| KR20220054908A (ko) | 2014-04-04 | 2022-05-03 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| US10179776B2 (en) | 2014-06-09 | 2019-01-15 | Intra-Cellular Therapies, Inc. | Compounds and methods of use to treat schizophrenia |
| CA2953546A1 (en) * | 2014-06-24 | 2015-12-30 | Taho Pharmaceuticals | Fast acting orally disintegrating film |
| KR20170117374A (ko) * | 2014-12-09 | 2017-10-23 | 모노졸 알엑스, 엘엘씨 | 선형 다당류-기반 필름 생성물 |
| CN105193772A (zh) * | 2015-10-28 | 2015-12-30 | 陈跃坚 | 一种沙格列汀口腔膜剂及其制备方法 |
| CN122182527A (zh) * | 2016-05-05 | 2026-06-12 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
| EP3452024A1 (en) * | 2016-05-05 | 2019-03-13 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
-
2019
- 2019-09-05 WO PCT/US2019/049725 patent/WO2020051317A1/en not_active Ceased
- 2019-09-05 EP EP19797399.3A patent/EP3846778A1/en active Pending
- 2019-09-05 CN CN201980073077.2A patent/CN112955124A/zh active Pending
- 2019-09-05 CN CN202411090113.5A patent/CN120789028A/zh active Pending
- 2019-09-05 US US16/561,573 patent/US11541002B2/en active Active
- 2019-09-05 BR BR112021004053-6A patent/BR112021004053A2/pt unknown
- 2019-09-05 JP JP2021512652A patent/JP7637616B2/ja active Active
- 2019-09-05 CA CA3110997A patent/CA3110997A1/en active Pending
-
2022
- 2022-11-17 US US17/989,307 patent/US12403090B2/en active Active
- 2022-12-30 US US18/091,556 patent/US12290597B2/en active Active
-
2025
- 2025-02-17 JP JP2025023573A patent/JP2025093925A/ja active Pending
- 2025-05-02 US US19/197,655 patent/US20250339367A1/en active Pending
- 2025-08-08 US US19/295,202 patent/US20260034059A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2717852B1 (en) | Edible oral strip or wafer dosage form containing ion exchange resin for taste masking | |
| ES2692890T3 (es) | Formulaciones líquidas que comprenden un agente activo, glicerina y sorbitol | |
| ES2706481T3 (es) | Forma de dosificación en película oral humectable de forma instantánea sin tensioactivo o polialcohol | |
| HU229394B1 (hu) | Leheletfrissítõ film | |
| WO2003063603A1 (en) | Hard sugar coated preparations, sugar coating solutions and process for producing hard sugar coated preparation | |
| WO2008018371A1 (fr) | Comprimé à désagrégation orale ayant un goût amer masqué et son procédé de production | |
| JP3631782B2 (ja) | ウルソデオキシコール酸を含む液体投与形態の薬剤 | |
| JP6049624B2 (ja) | 苦味のある薬物のための経口用医薬フィルム製剤 | |
| BRPI0709719A2 (pt) | formas de dosagem sàlida revestidas de pelÍcula | |
| CN1431874A (zh) | 聚磷酸盐作为牙齿侵蚀抑制剂在酸性组合物中的用途 | |
| JP2016526914A (ja) | タンパク質を含むマトリクス中にマイクロカプセル化風味料を含む、チューインガム組成物 | |
| BR112021016421A2 (pt) | Minimização de aglomeração, aeração e preservação do revestimento de composições farmacêuticas que compreendem ibuprofeno | |
| CN103763935B (zh) | 可降解的咀嚼型胶基糖以及制作所述可降解的咀嚼型胶基糖的方法 | |
| KR100963051B1 (ko) | 입자크기가 조절된 술포데히드로아비에트산을 함유한쓴맛이 저감된 경구용 액상 조성물 | |
| ES2793534T3 (es) | Composición como medio auxiliar para medicación oral | |
| LV11818B (en) | Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide | |
| RU2016130051A (ru) | Жидкие композиции рацекадотрила | |
| HU219334B (en) | Antacid composition and process for its production | |
| US20190240187A1 (en) | Oral preparations with omeprazole or pantoprazole | |
| WO2006118137A1 (ja) | ビグアナイド系薬物を含有する粒状製剤 | |
| CN115969820B (zh) | 一种孟鲁司特钠口腔溶膜剂及其制备工艺 | |
| JP2009514857A5 (cg-RX-API-DMAC10.html) | ||
| HRP20220691T1 (hr) | Poboljšanja u i u vezi s pripravcima | |
| CN107007565A (zh) | 一种盐酸鲁拉西酮口崩片及其制备方法 | |
| JP5009707B2 (ja) | 不快な味がマスキングされたキノロン系抗菌剤の経口投与用液剤 |